nCage Therapeutics is developing a novel synthetic protein cage based on the bacterial TRAP protein.
Protein cages are synthetic virus-like particles (VLPs), that can be used to display biological material on their surface, or transport molecules such as nucleic acids or proteins into the interior of the cell. Our cages are programmable and have significant potential as both drug delivery systems and vaccines.
Company Details
- Employees
- 7
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://ncage.org/
Ncage Therapeutics Questions
Ncage Therapeutics's website is https://ncage.org/
Ncage Therapeutics's LinkedIn profile is https://www.linkedin.com/company/ncage-therapeutics
Ncage Therapeutics has
7 employees.
View email and phone details for 7
employees at Ncage Therapeutics.
Ncage Therapeutics's industry is
Biotechnology Research
Ncage Therapeutics's top competitors are
Polbionica,
Nanogroup S.a.,
Onebiome Sp. Z O.o.,
Acatavir,
Selvita,
Auxilius Pharma,
Lam-X A.s.,
Molecure,
Ryvu Therapeutics,
Chimagen Biosciences.
Ncage Therapeutics's categories are Biotechnology Research
